Eloxx Pharmaceuticals, Inc.

ELOX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
424B3 Oct 22, 2026 424B3
8-K Oct 22, 2026 8-K
4 Oct 21, 2026 4
3 Oct 21, 2026 3
EFFECT Sep 18, 2026
S-1 Sep 11, 2026 S-1
SCHEDULE 13G Aug 14, 2026
SCHEDULE 13G Aug 14, 2026
8-K Aug 11, 2026 8-K
10-Q Aug 11, 2026 10-Q
SCHEDULE 13G Jul 27, 2026
SCHEDULE 13G Jun 17, 2026
SCHEDULE 13G Jun 17, 2026
4 Jun 17, 2026
3 Jun 17, 2026
SCHEDULE 13G Jun 16, 2026
SCHEDULE 13G Jun 16, 2026
SCHEDULE 13G Jun 15, 2026
4 Jun 10, 2026 4
4 Jun 10, 2026 4
4 Jun 10, 2026 4
4 Jun 10, 2026 4
4 Jun 10, 2026 4
424B4 Jun 9, 2026 424B4
EFFECT Jun 8, 2026
← Newer Page 1 of 54 · 1332 filings Older →